23andMe Holding Co.

Ownership Transactions Reported by 20 Insiders

Symbol
ME on Nasdaq
Industry
Pharmaceutical Preparations
Location
349 Oyster Point Boulevard, South San Francisco, California

Insiders trading volume in the past year

23andMe Holding Co. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Joseph Selsavage Chief Financial & Actng Ofcr $1.23 M May 21, 2024
Paul D. Johnson VP, General Manager-Consumer $939 K Feb 9, 2022
Evan Lovell Director $879 K Aug 11, 2022
Kathy L. Hibbs Chief Administrative Officer $665 K -$768 K -53.6% May 20, 2024
William Richards Head of Therapeutics Discovery $345 K -$2.74 K -0.79% May 20, 2024
Roelof Botha Director, 10%+ Owner $217 K Sep 6, 2023
Sandra Hernandez Director $216 K Jun 30, 2024
Patrick Chung Director $216 K Sep 6, 2023
Rice Valerie Md Montgomery Director $194 K Jun 30, 2024
Steven Lemon Vice President, Engineering $193 K Feb 9, 2022
Peter Taylor Director $176 K Jun 30, 2024
Neal Mohan Director $176 K Sep 6, 2023
Richard H. Scheller Director $170 K Sep 6, 2023
Kenneth J. Hillan Chief Therapeutics Officer $159 K Jun 5, 2023
Steven J. Schoch Chief Financial Officer $151 K Aug 20, 2022
Tracy Keim VP, Consumer Marketing & Brand $89.4 K Feb 9, 2022
Frederick Kohler Vice President, People $51.1 K Feb 9, 2022
Anne Wojcicki Chief Executive Officer, Director, 10%+ Owner Sep 15, 2023
Sc Us (Ttgp), Ltd. 10%+ Owner Jun 16, 2021
GSK plc 10%+ Owner Jun 16, 2021

Recent Insider Transactions by Companies or Individuals for 23andMe Holding Co.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership